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 A 15-year-old girl, who was previously in good health, 
suddenly collapsed while jogging. Immediate cardiopulmon-
ary resuscitation (CPR) was initiated, and she arrived at 
our hospital 13 minutes later. The ventricular fibrillation 
(VF) on admission was reverted to sinus rhythm 18 minutes 
after collapse by the second cardioversion. The echocardio-
gram revealed hypertrophic nonobstructed cardiomyopathy 
(HNOCM), although the 24hr ambulatory electrocardiogra-
phic, electrophysiologic and exercise stress tests could not 
define the exact cause of VF. Exercise-induced ischemia 
with sustained mild hypokalemia was suspected to be the 
cause of VF. The patient recovered consciousness three days 
after admission, and followed an uneventful course of 
treatment with oral atenolol not associating with disabling 
neurological deficit. 
 Immediate basic life support and delivery of automatic 
external defibrillator on the spot is needed to rescue pa-
tients with out-of-hospital cardiac arrest.
Key Words: cardiopulmonary resuscitation (CPR), 
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Introduction
 Hypertrophic cardiomyopathy (HCM) is a heteroge-
neous disease genotypically, phenotypically, patho-
physiologically and therapeutically"). Sudden death is 
a common complication of HCM, especially in adoles-
cents and young adults. Although the annual mortal-
ity rate from sudden death is 2 to 3% in adults, it is
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even higher (approximately 6%) in young patients3). 
Unexpected sudden cardiac death (SCD) of young ath-
letes occurs in approximately 1 of 200,000 high school 
athletes per academic year'). Even if electrocardiogra-
phic abnormalities were detected at annual school 
physical examinations, some young individuals report-
edly had SCD during school physical education classes. 
This was due to delayed or lack of further investiga-
tion, and requires precise evaluation systems. However, 
the authority of permitting each young patient with 
hypertrophic nonobstructed cardiomyopathy 
(HNOCM) to perform exercise is dependent on individ-
ual physician judgement. Such judgement sometimes 
may differ since some patients sometimes show nei-
ther severe symptoms nor significant pressure gradient 
of the left ventricular outflow tract. 
 Ventricular fibrillation (VF) is the most common 
mechanism of SCD, and some of the conditions facili-
tating VF include bradycardia, long QT syndrome, 
electrocution, electrolyte imbalance, drugs, sympathetic 
stimulation and myocardial ischemia. If young, cardiac 
arrest survivors were rescued with longstanding cere-
bral damages, their quality of life would be aggra-
vated. We herein report a case with dramatic, success-
ful resuscitation from cardiac arrest remaining no 
cerebral damage in a young asymptomatic female with 
previous unknown HCM.
Case Report
 A 15-year-old, high school student, who had been 
well and playing volleyball during middle high school 
days, had an electrocardiographic abnormality noted 
on April 22, 1998. It showed negative T wave in leads 
II, III, aVf, V, through V6 and high amplitude of R 
wave in V, through V3 without QT interval prolonga-
tion (QTc interval = 0.41 seconds) (Fig. 1). She was 
scheduled for admission to a university hospital on
Fig. 1, Electrocardiogram on April 22, 1998. 
Negative T wave in leads II, III, Vf, V, through V6 and 
high amplitude of R wave in V, through V3 were 
shown. QTc interval was 0.41 seconds.
Fig. 2. Electrocardiogram on June 3, 1998. 
Ventricular fibrillation was reverted to sinus rhythm after DC 
cardioversion. (a: before cardioversion ; b: after cardioversion ) 
DC cardioversion : direct current cardioversion
June 4, 1998 for further diagnostic investigation. She 
had been suffering from diarrhea for two months 
owing to irritable colitis. Her grandfather and uncle 
had left ventricular hypertrophy without definite diag-
nosis. There was no family history of sudden death, 
congestive heart failure and lethal heart diseases. 
 At 10: 35 a.m. on June 3, 1998, the patient collapsed 
suddenly on the school grounds while jogging approxi-
mately 300 meter in distance during physical educa-
tion. Basic life support was started immediately by a 
teacher, and a first-responding fire fighter vigorously 
initiated CPR two minutes later. The patient was 
brought to our hospital by ambulance 13 minutes 
after collapse, with mydriasis, weak spontaneous respi-
ration and E-1, V-1 and M-1 of the Glasgow Coma 
Scale (GCS), or 111-300-A of Japan Coma Scale (JCS). 
The initial rhythm was VF, and the second direct
current (DC) cardioversion reverted VF to sinus 
rhythm 18 minutes after collapse (Fig. 2-a, b). A clini-
cal time table is shown in Table 1. The arterial blood 
gas, complete blood cell count and serum biochemical 
analysis on admission to our hospital are shown in 
Table 2. Echocardiographycally, the wall thickness of 
the interventricular septum (IVS) was 22.5mm ; ante-
rior left ventricular wall 19.3mm ; lateral left ventricu-
lar wall 14.0mm ; posterior left ventricular wall 
11.3mm (Fig. 3). Neither left ventricular outflow tract 
obstruction nor systolic anterior motion (SAM) of the 
anterior mitral valve leaflet was present. Our diagnosis 
was HNOCM with mild mitral regurgitation. 
 Since her coma scale was improved (El, V1, M4 of 
GCS or 111-100 of JCS) with hemodynamic stability 
(Table 1), the patient was transferred to the univer-
sity hospital for hyperbaric oxygen therapy (HOT).
Table 1. Clinical Time Table on June 3, 1998
  Time Clinical Course GCS 
10:35 a. m. Collapse on the school ground E1, V1, Ml 
10:40 a. m. Ambulance's arrival in the shool ground El, Vi, M1 
10:48 a. m. Patient's arrival at hospital; BP: unmeasurable E1, V1, M1 
10:52 a. m. Intratrcheal intubation The first delivery of 360J of DC cardioversion E1, V1, M1 
10:53 a. in. The second delivery of 360J of DC cardioversion E1, V1, Ml 
10:56 a.m. BP: 104/-mmHg E1, V1, M2 
11:15 a.m. BP : 120/56mmHg El, V1, M4 
12:50 a.m. BP : 150/88mmHg El, V1, M4 
01:00 p.m. Transfer to the university hospital El, V1, M4
BP: blood pressure 
DC cardioversion: direct current cardioversion 
GCS: Glasgow Coma Scale
However, the patient did not require HOT; due to im-
proved cerebral function, and received glycerol and po-
tassium L-aspartate intravenously for five days to cor-
rect hypokalemia (K=2.7mEq/L in the university 
hospital on June 3). Three days after admission, the 
patient recovered to E-4, V-4 and M-6 of GCS or I-1 of 
JCS without neurological deficits, and the value of po-
tassium was corrected to 4.OmEq/L. 
 On June 17, 1998, left ventriculography and 
biventriculography demonstrated hypertrophic IVS
with normal coronary arteriogram and slightly ele-
vated left ventricular end-diastolic pressure (LVEDP) 
(Fig.4, 5, Table 3). There was no pressure gradient be-
tween the left ventricular outflow tract and the aorta.
Table 2. Blood Gas, Complete Blood Cell Count and Serum 
Biochemical Data at 10:54 a.m. on June3, 1998
pH 6.98pH units AST 36U/f 
PCO2 35.7mmHg ALT 25U/P 
P02 306.4mmHg LDH 342U/i 
(with 10 f /min oxygen) CK 95U/~ 
HC03- 8.4mmol/f Na 140mE/t 
Base Excess -23.6mmol/ K 3.7mEq/e 
WBC 9900/ e Cl 95mEq/4 
RBC 520x 104/,U BUN 121mg/dt 
Hgb 17.1g/df Creatinine 1.0mg/d4 
Pit 14.7x104/ £ CRP 0.4mg/de
Table 3. Hemodynamic Variables
                Systole Diastole Mean EDP 
PAWP mmHg * * 10 
PA mmHg 25 11 16 * 
RV mmHg 29 1 * 6 
RA mmHg * * 3 * 
LV mmHg 90 9 * 17 
Ao mmHg 100 60 80 *
Ao: aorta 
EDP: end-diastolic pressure 
PA: pulmonary arterial pressure 
PAWP: pulmonary arterial wedge pressure 
RA: right atrium 
RV: right ventricle 
*: not available
Fig. 3. Echocardiogram on June 3, 1998. 
Echocardiogram showed hypertrophy of the interventricular sep-
tum and the anterior left ventricular wall (a : long axis view ; b: 
short axis view) 
A : anterior left ventricular wall 
IVS : interventricular septum 
LV : left ventricule
Ventricular tachycardia (VT), VF and supraventricular 
tahcycardia (SVT) were not induced by programmed 
ventricular stimulation, isoproterenol provacation and 
by exercise stress test. The 24hr ambulatory electro-
cardiogram (24hr ECG) also failed to identify any 
arrhythmias. 
 The patient was given 25mg/day of atenolol orally, 
and was discharged without any neurological sequelae 
on June 9, 1998. She has been following an uneventful 
course without worsening her daily quality of life.
mass ("possible HCM") (10%), aberrant coronary ar-
teries (13%), other coronary anomalies (6%), ruptured
Discussion
 Coronary artery disease is the most common cause 
of sudden death in those over the age of 35 years. In 
contrast, structural cardiovascular abnormalities, in-
cluding HCM (36%), unexplained increased cardiac
Fig. 4. Coronary angiogram on June 17, 1998. 
Coronary angiogram showed no significant stenosis of the left 
(a) and the right coronary arteries.
Fig. 5. Left ventriculography (a: end-diastole ; b : end-systole) 
and biventriculography (c) on June 17, 1998. 
Marked hypertrophy of the interventricular septum was dem-
onstrated. 
IVS : interventricular septum
aortic aneurysm(5%), tunneled LAD(5%) and aortic 
valve stenosis(4%) are the major causes of sudden 
death in young athletes(< age 35)5'. HCM is present 
in about 2 of 1,000 young adults and its prevalence in 
men and women is 0.26 : 0.09%6'. Sudden death is 
often the first manifestation in an asymptomatic pa-
tient with HCM, and occurs during or immediately 
after moderate or heavy physical activity". Although 
the precise mechanisms by which exercise precipitates 
SCD in person with HCM is unclear, potential mecha-
nisms are as follows : (1) VT or SVT arise in the dis-
arrayed muscle or in ischemic areas of small vessel 
disease ; (2) sudden hemodynamic instability occurs 
involving dynamic increase in the left ventricular out-
flow tract obstruction ; (3) exercise-induced systemic 
hypotension occurs by activating ventricular 
baroreceptor reflex, resulting in withdrawal of sympa-
thetic tone$', or abnormal vascular response to exercise 
occurs due to increased sensitivity of arterial 
baroreflexes9' ; (4) VF arising from VT is induced by 
ischemia due to shortening of diastole or hypotension 
during exercise-induced tachycardia and (5) impair-
ment of coronary flow or aggravation of the left ven-
tricular filling occurs during exercise, or mental 
excitement"). We could not identify the definite cause 
of cardiac arrest and VF, because neither sustained VT 
nor nonsustained VT were detected with electrophysio-
logic study, 24hr ECG and exercise stress testing. 
 In a series of 115 patients immediately after resusci-
tation from out-of hospital VT, resuscitated patients re-
vealed that admission mean serum potassium value 
was 3.70__F0.72(SD) mEq/L, compared with 4.09±0.6 
6 mEq/L in acute myocardial infarction, and 4.17±0. 
35 mEq/L in patients with coronary heart disease"'. 
Exercise-induced ischemia with sustained mild 
hypokalemia owing to irritable colitis may be a cause 
of V F in our case. 
 The mainstay treatment of HCM is drug therapy 
using beta-blockers, calcium antagonists and other 
drugs including disopyramide, diuretics and 
antivitamin K agents"). The benifits of beta-blockers 
are significant reduction in nonfatal cardiac arrest in 
the short term trials and sudden cardiac death in long 
term trials, which are likely due to relief ischemia, re-
duction of heart rate and maintenance of favorable 
autonomic nervous system balance"). Amiodarone is 
reported to improve symptoms and to prevent sudden 
death in patients with HCM. In the study of 
amiodarone treatment refractory to conventional drug 
therapy(beta-blockers and calcium antagonist), eight 
out of 50 patients treated with amiodarone died dur-
ing mean follow-up period of 2.2± 1.8 years, and the 
survival rate of patients with VT was significantly
worse than that of patients without VT 13'. Decrease in 
peak left ventricular filling rate within 10 days of 
amiodarone therapy was associated with subsequent 
sudden death13'. While recent studies have indicated 
that nonsustained ventricular tachycarida in 
asymptomatic patients without additional risk factors, 
such as a positive family history of sudden death or 
syncope should not be treated prophylactically with 
amiodarone, and symptomatic patients with sustained 
ventircular tachycardias and/or syncope related to 
ventricular arrhythmias should undergo implantable 
cardioverter-defibrillator (ICD) implantation"'. Elliott 
et al. showed that ICD was probably superior to low 
dose amiodarone in patients with HCM who survived 
a cardiac arrest owing to an episode of VT/VF"'. 
Kron et al. also emphasized that the ICD represented 
an effective treatment approach for young patients 
less than 20 years old with life-threatening ventricular 
tachyarrhythmias16'. The patient of our case will need 
to implant ICD when a VT/VF episode occurs in the 
future. 
 Weaver et al. reported that both the period from col-
lapse until initiation of basic life support and the dura-
tion of basic life support before delivery of the first 
defibrillatory shock were shorter in patients who sur-
vived compared with those died (3.6±2.5 versus 6.1 
± 3.3minutes and 4.3±3.3 versus 7.3±4.2 minutes) "'. 
Mortality increased by 3 % each minute until CPR was 
begun and by 4% a minute until the first shock was 
diliveredt8'. Survival from VF can be improved by 
shortening the delay of CPR initiation and to defibril-
lation. Therefore, it is necessary to increase the num-
ber of qualified persons who can use an automatic ex-
ternal defibrillator and to authorize them to attempt it 
without the permission of a physician in some urgent 
cases. Furthermore, many doctors should have interest 
in CPR, and actively educate and enlighten the general 
citizen on the basic life support maneuvers required to 
decrease morbidity and mortality from serious dis-
eases.
- A part of this manuscript was presented at the 6th 
annual Nagasaki Emergency Medical Association on 
Sep. 12, 1998.-
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